Drug delivery device with container holder

Abstract

The drug delivery device includes a housing, a needle having a retracted position and an extended position, a needle manipulation body received within the housing and configured to move from a pre-use position in which the needle is in the retracted position to a use position in which the needle is in the extended position, the container having a first position and a second position axially spaced from the first position, the container received within the housing, and an operating button movable from the first position to the second position relative to the housing to actuate the needle manipulation body from the pre-use position to the use position, the operating button including a container holder configured to limit movement of the container from the first position to the second position when the needle manipulation body is in the pre-use position.

Description

[Technical Field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to U.S. Provisional Application No. 63 / 116,024, entitled "Drug Delivery Device with Container Holder," filed November 19, 2020, the entire disclosure of which is incorporated herein by reference.

[0002] The present disclosure relates to drug delivery devices. [Background technology]

[0003] Various types of automatic injection or drug delivery devices have been developed to allow medications and other liquid therapeutic formulations to be administered or self-injected by untrained personnel. These devices typically include a reservoir prefilled with the liquid therapeutic formulation and some type of automatic needle injection mechanism that can be triggered by the user. Automatic injectors are commonly used when the volume of fluid or medication to be administered is a fixed volume, typically 1 mL, or less, and the injection time is typically approximately 10 to 1 second. When the volume of fluid or medication to be administered exceeds 1 mL, the injection time generally becomes longer, making it difficult for the patient to maintain contact between the device and the target site on the patient's skin. Furthermore, the larger the volume of medication to be administered, the longer the injection time is desired. The traditional method of slowly injecting medication into a patient is to start an IV drip and slowly inject the medication into the patient's body. Such procedures are typically performed in hospitals or outpatient settings. Summary of the Invention [Problem to be solved by the invention]

[0004] Certain devices allow for self-injection in a home setting, gradually infusing a liquid therapeutic formulation into a patient's skin. In some cases, these devices are small enough (both in height and overall size) to be "worn" by the patient while the liquid therapeutic formulation is being injected into the patient. These devices typically include a pump or other type of delivery mechanism that forces the liquid therapeutic formulation from a reservoir into the injection needle. Such devices also typically include a valve or flow control mechanism to initiate the flow of the liquid therapeutic formulation at the appropriate time, and a trigger mechanism to initiate the injection. [Means for solving the problem]

[0005] In one aspect or embodiment, a drug delivery device includes a housing, a needle having a retracted position and an extended position, a needle manipulation body received within the housing and configured to move from a pre-use position in which the needle is in the retracted position to a use position in which the needle is in the extended position, a container received within the housing, and an actuator button movable from a first position to a second position relative to the housing to actuate the needle manipulation body from the pre-use position to the use position. The container includes a body, a closure, and a stopper movable within the body, and the container has a first position and a second position axially spaced from the first position. The actuator button includes a container holder configured to limit movement of the container from the first position to the second position when the needle manipulation body is in the pre-use position.

[0006] The vessel holder may be a protrusion configured to engage with the body of the vessel. The body of the vessel may include a flange, and the vessel holder is configured to engage with the flange of the vessel.

[0007] The device may further include a valve assembly including a valve boot and a valve needle, wherein the container is spaced from the valve assembly when the container is in the first position and the container is engaged with the valve assembly when the container is in the second position.

[0008] The device can further include a drive assembly configured to move the container from the first position to the second position and to move the stopper relative to the body of the container. The operating button can be configured to actuate the drive assembly.

[0009] The needle handling body may include a protrusion configured to limit movement of the container from the first position to the second position when the needle handling body is in the pre-use position. The protrusion of the needle handling body may be spaced from the container holder of the operating button in a direction extending perpendicular to the longitudinal axis of the housing.

[0010] The operating button may be spaced apart from the container when the container is in the second position. The container holder may also be formed integrally with the operating button. [Brief explanation of the drawings]

[0011] The above and other features and advantages of the present disclosure, and the manner in which they are achieved, will become more apparent, and the disclosure itself will be better understood, by reference to the following description of embodiments of the disclosure taken in conjunction with the accompanying drawings. [Figure 1] FIG. 1 is a perspective view of a drug delivery device according to one aspect or embodiment of the present application. [Figure 2] 2 is a perspective cross-sectional view of the drug delivery device of FIG. 1. FIG. [Figure 3] 3 is a front cross-sectional view of the drug delivery device of FIG. 1. FIG. [Figure 4] FIG. 4 is a top view of the drug delivery device of FIG. 1 with the top of the housing removed, showing the drug delivery device in a pre-use position. [Figure 5] FIG. 5 is a top cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a pre-use position. [Figure 6] FIG. 6 is a front cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a pre-use position. [Figure 7]FIG. 7 is a top view of the drug delivery device of FIG. 1 with the top of the housing removed, showing the drug delivery device in an initial actuated position. [Figure 8] FIG. 8 is a top cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in an initial actuated position. [Figure 9] FIG. 9 is a front cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in an initial actuated position. [Figure 10] FIG. 10 is a top view of the drug delivery device of FIG. 1 with the top of the housing removed, showing the drug delivery device in the position for use. [Figure 11] FIG. 11 is a top cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in the position for use. [Figure 12] FIG. 12 is a cross-sectional front view of the drug delivery device of FIG. 1, showing the drug delivery device in the position for use. [Figure 13] FIG. 13 is a top view of the drug delivery device of FIG. 1 with the top of the housing removed, showing the drug delivery device in a post-use position. [Figure 14] FIG. 14 is a top cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a post-use position. [Figure 15A] FIG. 15A is a front cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a post-use position. [Figure 15B] FIG. 15B is a front cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a pre-use position. [Figure 15C] FIG. 15C is a perspective cross-sectional view of the drug delivery device of FIG. 1, showing the drug delivery device in a pre-use position. [Figure 16] FIG. 16 is a partial perspective view of the drug delivery device of FIG. 1 with the top of the housing removed, showing the drug delivery device in a pre-use position. [Figure 17] FIG. 17 is a partial perspective view of the drug delivery device of FIG. 1 with the top of the housing removed, showing the drug delivery device in a pre-use position.

[0012] Corresponding reference characters indicate corresponding parts in the several views. The illustrations presented herein illustrate exemplary embodiments of the present disclosure, and such illustrations should not be construed as limiting the scope of the present disclosure in any way. DETAILED DESCRIPTION OF THE INVENTION

[0013] The following description is provided to enable any person skilled in the art to make and use the described embodiments contemplated for practicing the invention. However, various modifications, equivalents, variations, and alternatives will be readily apparent to those skilled in the art. Any and all such modifications, variations, equivalents, and alternatives are intended to be within the spirit and scope of the present invention.

[0014] Hereinafter, for purposes of explanation, the terms "upper," "lower," "right," "left," "vertical," "horizontal," "top," "bottom," "transverse," "longitudinal," and their derivatives will refer to the present invention as oriented in the drawings. However, it will be understood that the present invention may assume various alternative modifications unless expressly specified to the contrary. It should also be understood that the specific devices illustrated in the accompanying drawings and described in the following specification are merely exemplary embodiments of the present invention. Therefore, specific dimensions and other physical characteristics relating to the embodiments disclosed herein are not to be considered limiting.

[0015] 1-17 , a drug delivery device 10 includes a drive assembly 12, a reservoir 14, a valve assembly 16, and a needle handling body 18. The drive assembly 12, the reservoir 14, the valve assembly 16, and the needle handling body 18 are at least partially disposed within a housing 20. The housing 20 includes a top 22 and a bottom 24, although other suitable configurations for the housing 20 may be utilized. In one aspect, the drug delivery device 10 is an injector device configured to be worn or secured to a person and to deliver a predetermined dose of a medication provided in the reservoir 14 to the person via injection. The device 10 may be utilized for a "bolus injection," which administers medication over a period of time. The medication may be administered over a period of up to 45 minutes, although other suitable injection volumes and durations may be utilized. The bolus or administration may be rate-controlled or uncontrolled. The device 10 may deliver medication to the user at a constant pressure, but the rate may be variable. The general operation of the device 10 is described below with reference to FIGS.

[0016] 1-17 , device 10 is configured to be actuated by a user engaging actuation button 26, resulting in needle 28 of needle manipulation assembly 18 penetrating the user's skin, and actuation of drive assembly 12 to place needle 28 in fluid communication with container 14, expel fluid or medication from container 14, and withdraw needle 28 after medication infusion is complete. Operation of device 10 may be similar to that described in U.S. Patent Application Publication No. 2017 / 0354788, the entire contents of which are incorporated herein by reference. Housing 20 of device 10 includes indicator window 30 for viewing indicator arrangement 32 configured to provide a user with an indication regarding the status of device 10, and container window 31 for viewing container 14. Indicator window 30 may be a magnifying lens for clearly viewing indicator arrangement 32. The indicator arrangement 32 moves with the needle manipulation assembly 18 during use of the device 10 to indicate the pre-use, use, and post-use states of the device 10. The indicator arrangement 32 provides a visual indication of the state, although other suitable indications, such as audio or tactile, may alternatively or additionally be provided.

[0017] 4-6, during the pre-use position of device 10, container 14 is spaced from drive assembly 12 and valve assembly 16, and needle 28 is in an extended position. As shown in FIGS. 7-9, during initial actuation of device 10, drive assembly 12 is engaged with container 14 after movement of actuator 26, disengaged, and moves container 14 from a first position to a second position axially spaced from the first position, engaging valve assembly 16. Moving container 14 toward valve assembly 16 penetrates closure 36 of container 14, placing the medicament within container 14 in fluid communication with needle 28 via tubing 37 or other suitable arrangement. Drive assembly 12 is configured to engage stopper 34 located within body or barrel 35 of container 14, and the incompressibility of the fluid or medicament within container 14 initially moves the entire container 14 into engagement with valve assembly 16. Initial actuation of device 10 is caused by the user engaging actuator button 26, which releases needle manipulation assembly 18 and drive assembly 12, as described in more detail below. During initial actuation, needle 28 is still in the retracted position and attempts to move to the extended position to provide an injection to the user of device 10.

[0018] 10-12, during the use position of device 10, needle 28 is at least partially outside of housing 20 in an extended position, and drive assembly 12 moves stopper 34 within container 14 to deliver medication from container 14 through needle 28 to a user. In the use position, valve assembly 16 has already pierced closure 36 of container 14 to place container 14 in fluid communication with needle 28, thereby allowing fluid to be dispensed from container 14, and drive assembly 12 can also move stopper 34 relative to container 14. In the post-use position of device 10, shown in FIGS. 13-15A, needle 28 is in a retracted position, engaging pad 38 to seal needle 28 and prevent residual flow of fluid or medication from container 14.

[0019] Referring again to FIGS. 1 through 17 , the needle handling assembly 18 includes a needle handling body 40 that is received within the housing 20 and configured to move from a pre-use position ( FIGS. 3 through 6 ), in which the needle 28 is in a retracted position, to a use position ( FIGS. 10 through 12 ), in which the needle 28 is in an extended position. In the retracted position, the needle 28 is disposed entirely within the housing 20, and in the extended position, the needle 28 is disposed at least partially outside the housing 20. The needle handling body 40 also has a post-use position ( FIGS. 13 through 15A ), in which the needle 28 is in the retracted position and engages the pad 38, as described above. The needle handling body 40 is biased from the pre-use position to the post-use position by a spring 42. As described above, the operating button 26 is movable relative to the housing 20 from a first position to a second position to actuate the needle handling body 40 from the pre-use position to the use position. In one aspect or embodiment, movement of the actuator button 26 from the first position to the second position moves the needle handling body 40 out of engagement with the housing 20 or another component, allowing the spring 42 to bias the needle handling body 40 from the pre-use position to the use position and to the post-use position. The needle handling body 40 moves the needle 28 between the retracted and extended positions via a cam mechanism as the needle handling body 40 moves between the retracted and extended positions, although other suitable arrangements may be utilized.

[0020] 5, 8, and 11, in one aspect or embodiment, the valve assembly 16 includes a valve boot 50, a valve needle 52, a valve sleeve 54, and a piercing plate 56, although other suitable valve arrangements may be utilized. During use, the closure 36 of the container 14 initially contacts the valve boot 50 (FIG. 8) and compresses the valve boot 50 until the piercing plate 56 penetrates the valve boot 50. When the container 14 is moved to the position shown in FIG. 11, the valve boot 50 is fully compressed, the valve sleeve 54 is compressed, and the valve needle 52 extends through the closure 36 of the container 14, placing the contents of the container 14 in fluid communication with the valve needle 52. As described above, the valve needle 52 is in fluid communication with the needle 28 via the tubing 37. In one aspect or embodiment, the closure 36 of the container 14 includes a foil seal, a septum, and a locking collar, although other suitable arrangements may be utilized.

[0021] 16 and 17 , the operating button 26 includes a container holder 70 configured to limit movement of the container 14 from the first position to the second position when the needle operating body 40 is in the pre-use position. In one aspect or embodiment, the container holder 70 is configured to prevent the container 14 from moving into engagement with the valve assembly 16 before the device 10 is actuated if the device 10 is dropped or subjected to sudden acceleration or deceleration. Contact between the container 14 and the valve assembly 16 could puncture the valve boot 50 or other portions of the valve assembly 16, or puncture a portion of the closure 36 of the container 14, compromising the sterility of the container 14 or valve assembly 16. The container holder 70 is a rectangular protrusion configured to engage the body 35 of the container 14. In certain configurations, the protrusion can be square, cylindrical, or any other suitable shape. In one aspect or embodiment, the container holder 70 engages a flange 72 of the container 14. In one aspect or embodiment, the container holder 70 is integrally formed with the operating button 26, however, the container holder 70 may be formed separately from the operating button 26.

[0022] When the needle manipulation body 40 is in the pre-use position and before the device 10 is actuated, the container holder 70 limits movement of the container 14 if the device 10 is dropped. In one aspect or embodiment, the container holder 70 is spaced a predetermined distance from the flange 72 of the container 14 to prevent movement of the container 14 before the container 14 engages the valve assembly 16, while avoiding interference with the container 14 after the device 10 is actuated. There should be a gap between the container holder 70 and the outer periphery of the container 14 that allows the container holder 70 to absorb the load of barrel movement. Therefore, the operating button 26 is spaced from the container 14 during use of the device 10.

[0023] 4 and 5 , the needle handling body 40 includes a protrusion 80 configured to limit movement of the container 14 from a first position to a second position when the needle handling body 40 is in the pre-use position. The protrusion 80 of the needle handling body 40 is spaced apart from the container holder 70 of the operating button 26 in a direction extending perpendicular to the longitudinal axis of the housing 20. In one aspect or embodiment, the protrusion 80 is configured to contact the bottom of the flange 72 of the container 14, and the container holder 70 is configured to contact the top of the flange 72 of the container 14. Providing two points of contact with the container 14 prevents the container 14 from contacting the valve assembly 16 prior to actuation of the device 10, for all orientations in which the device 10 may be dropped. Simply contacting the bottom of the flange 72 may allow rocking or other movement of the container 14 for certain orientations in which the device 10 is dropped, which may allow undesired contact between the container 14 and the valve assembly, as discussed above.

[0024] Elements of one disclosed aspect can be combined with elements of one or more other disclosed aspects to form different combinations, all of which are contemplated within the scope of the present invention.

[0025] While this disclosure has been described as having exemplary constructions, the disclosure can be further modified within the spirit and scope of the disclosure. Accordingly, this application is intended to cover any variations, uses, or adaptations of the disclosure using its general principles. Further, this application is intended to cover such departures from the disclosure as come within known or customary practice in the art to which this disclosure pertains and fall within the scope of the appended claims.

Claims

1. The drug delivery device Housing and a needle having a retracted position and an extended position; a needle manipulation body received within the housing and configured to move from a pre-use position in which the needle is in the retracted position to a use position in which the needle is in the extended position; a container received within the housing, the container including a body, a closure, and a stopper movable within the body, the container having a first position and a second position axially spaced from the first position; a valve assembly including a valve boot and a valve needle, wherein the container is spaced from the valve assembly when the container is in the first position and is engaged with the valve assembly when the container is in the second position; an operating button movable from a first position to a second position relative to the housing to actuate the needle manipulation body from the pre-use position to the use position, the operating button comprising a container holder configured to limit movement of the container from the first position to the second position when the needle manipulation body is in the pre-use position, the container holder comprising a protrusion configured to engage the body of the container; Equipped with The needle handling body includes a protrusion configured to limit movement of the container from the first position to the second position when the needle handling body is in the pre-use position.

2. The drug delivery device of claim 1 , wherein the body of the container includes a flange, and the container holder is configured to engage the flange of the container.

3. 3. The drug delivery device of claim 1, further comprising a drive assembly configured to move the container from the first position to the second position and to move the stopper relative to the body of the container.

4. The drug delivery device of claim 3 , wherein the operating button is configured to actuate the drive assembly.

5. The drug delivery device of claim 1 , wherein the protrusion of the needle manipulation body is spaced apart from the reservoir holder of the manipulation button in a direction extending perpendicular to the longitudinal axis of the housing.

6. The drug delivery device of claim 1 , wherein the operating button is spaced apart from the container when the container is in the second position.

7. The drug delivery device according to claim 1 , wherein the container holder is integrally formed with the operating button.

Images